Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Inquis Medical's AVENTUS Thrombectomy System has received 510(k) clearance from the FDA for an expanded indication to treat pulmonary embolism.
-
AVENTUS Trial evaluating safety and efficacy of Inquis Medical's AVENTUS Thrombectomy System met primary endpoints, results presented today at SCAI.
-
Inquis Medical Completes Enrollment in AVENTUS US Pivotal IDE Trial of the Aventus Thrombectomy System Designed to Treat Patients with Pulmonary Embolism
-
Renowned vascular disease expert joins Silicon Valley clinical stage medical device company developing next-generation thrombectomy technology Inquis Medical also announces appointment of Bruce...